{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:01:41Z","timestamp":1746417701827,"version":"3.40.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"crossref","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Genetic variation is known to affect response to calcium channel blockers (CCBs) among different populations. This study aimed to determine the genetic variations associated with poor response to this class of antihypertensive drugs among Filipinos.<\/jats:p>\n            <jats:p>One hundred eighty one hypertensive participants on CCBs therapy were included in an unmatched case-control study. Genomic deoxyribonucleic acid were extracted and genotyped for selected genetic variants. Regression analysis was used to determine the association of genetic and clinical variables with poor response to medication.<\/jats:p>\n            <jats:p>The variant rs1458038 near <jats:italic toggle=\"yes\">fibroblast growth factor 5 gene<\/jats:italic> showed significant association with poor blood pressure-lowering response based on additive effect (CT genotype: adjusted OR 3.41, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001; TT genotype: adjusted OR 6.72, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001).<\/jats:p>\n            <jats:p>These findings suggest that blood pressure response to calcium channels blockers among Filipinos with hypertension is associated with gene variant rs1458038 near <jats:italic toggle=\"yes\">fibroblast growth factor 5 gene<\/jats:italic>. Further studies are recommended to validate such relationship of the variant to the CCB response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028703","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:00:44Z","timestamp":1643979644000},"page":"e28703","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The rs1458038 variant near FGF5 is associated with poor response to calcium channel blockers among Filipinos"],"prefix":"10.1097","volume":"101","author":[{"given":"Felix Eduardo R.","family":"Punzalan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Maria C.","family":"Cutiongco \u2013 de la Paz","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, National Institutes of Health, University of the Philippines, Manila"},{"name":"Philippine Genome Center, University of the Philippines, Diliman, Quezon City, Manila."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Jr. B.","family":"Nevado","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, National Institutes of Health, University of the Philippines, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Donato A.","family":"Magno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Ignacia D.","family":"Ona","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee Yvonne Criselle L.","family":"Aman","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, National Institutes of Health, University of the Philippines, Manila"},{"name":"Philippine Genome Center, University of the Philippines, Diliman, Quezon City, Manila."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Denver A.","family":"Tiongson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmer Jasper B.","family":"Llanes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Ferdinand M.","family":"Reganit","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Henry P.","family":"Tiongco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes Ella G.","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime Alfonso M.","family":"Aherrera","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro L.","family":"Abrahan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene F.","family":"Agustin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian John P.","family":"Bejarin","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, National Institutes of Health, University of the Philippines, Manila"},{"name":"Philippine Genome Center, University of the Philippines, Diliman, Quezon City, Manila."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-3973","authenticated-orcid":false,"given":"Rody G.","family":"Sy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of the Philippines \u2013 Philippine General Hospital, Manila"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115\u200amm Hg, 1990\u20132015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"R3-20250504","first-page":"2275","article-title":"2017\u200aACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"(3 Suppl)","key":"R4-20250504","first-page":"28S","article-title":"Pharmacology and mechanisms of action of calcium-channel blockers","volume":"2","author":"Katz","year":"1986","journal-title":"J Clin Hypertens"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1185\/030079903125001677","article-title":"Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine","volume":"19","author":"Kes","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(01)01728-4","article-title":"Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy","volume":"39","author":"Opie","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"key":"R9-20250504","first-page":"241","article-title":"Differences in hypertension between blacks and whites: an overview","volume":"18","author":"Lindhorst","year":"2007","journal-title":"Cardiovasc J Afr"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/hr.2010.259","article-title":"Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association","volume":"34","author":"Wang","year":"2011","journal-title":"Hypertens Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/14622416.7.3.271","article-title":"CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension","volume":"7","author":"Bremer","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000258688","article-title":"CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African American men and women with early hypertensive renal disease","volume":"31","author":"Bhatnagar","year":"2010","journal-title":"Am J Nephrol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1358\/mf.2007.29.1.1063490","article-title":"Genetic polymorphisms of the urea transporter gene are associated with antihypertensive response to nifedipine GITS","volume":"29","author":"Hong","year":"2007","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cpt.1585","article-title":"The Klotho variant rs36217263 is associated with poor response to cardioselective beta-blocker therapy among Filipinos","volume":"107","author":"Sy","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R15-20250504","first-page":"35","article-title":"BAG6 variant rs805303 is nominally associated with ACEi-induced cough among Filipinos","volume":"149","author":"Reganit","year":"2020","journal-title":"Phil J Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.361","article-title":"Genome-wide association study identifies eight loci associated with blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/ajh\/hpu263","article-title":"Variant near FGF5 has stronger effects on blood pressure in Chinese with a higher body mass index","volume":"28","author":"Li","year":"2015","journal-title":"Am J Hypertens"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cge.12974","article-title":"Association of genetic variation with blood pressure traits among East Africans","volume":"92","author":"Kayima","year":"2017","journal-title":"Clin Genet"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.110.153429","article-title":"Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project","volume":"56","author":"Tabara","year":"2010","journal-title":"Hypertension"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/HYPERTENSIONAHA.117.10268","article-title":"Blood pressure control by a secreted FGFBP1 (fibroblast growth factor\u2013binding protein)","volume":"71","author":"Tassi","year":"2018","journal-title":"Hypertension"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1378\/chest.126.4.1255","article-title":"Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension","volume":"126","author":"Benisty","year":"2004","journal-title":"Chest"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00005344-199805000-00019","article-title":"Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation","volume":"31","author":"Stepien","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.HYP.35.5.1038","article-title":"Influence of diabetes and type of hypertension on response to antihypertensive treatment","volume":"35","author":"Brown","year":"2000","journal-title":"Hypertension"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12933-016-0485-3","article-title":"Blood pressure control in type 2 diabetic patients","volume":"16","author":"Grossman","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/HYPERTENSIONAHA.111.00612","article-title":"Diabetes mellitus and vascular disease","volume":"61","author":"Sowers","year":"2013","journal-title":"Hypertension"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:06:56Z","timestamp":1746331616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028703","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"2021-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}